Korro Bio, Inc. (KRRO) Operating cash flow 2017–2025
Korro Bio, Inc. (KRRO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$78.6MFY2025 · since FY2017: -$14.6M → -$78.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$78.6M | -30.8% |
| FY2024 | -$60.1M | +10.7% |
| FY2023 | -$67.3M | -25.4% |
| FY2022 | -$53.6M | +29.5% |
| FY2021 | -$76.1M | -68.3% |
| FY2020 | -$45.2M | -232.1% |
| FY2019 | $34.2M | +301.0% |
| FY2018 | -$17.0M | -16.5% |
| FY2017 | -$14.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KRRO financial trends
KRRO RevenueKRRO Net incomeKRRO Net marginKRRO Gross profitKRRO Gross marginKRRO Operating incomeKRRO Operating marginKRRO Free cash flowKRRO Capital expendituresKRRO Return on equityKRRO Stock buybacksKRRO Dividends paidKRRO Total assetsKRRO Total liabilitiesKRRO Shareholders’ equityKRRO overview →